These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 9266106)
61. CD44 expression in soft tissue sarcomas. Kahara N; Ozaki T; Doi T; Nishida K; Kawai A; Shibahara M; Inoue H Virchows Arch; 2000 Jun; 436(6):574-8. PubMed ID: 10917171 [TBL] [Abstract][Full Text] [Related]
62. Alternatively spliced CD44 transcripts in diffuse large-cell lymphomas: characterization and comparison with normal activated B cells and epithelial malignancies. Salles G; Zain M; Jiang WM; Boussiotis VA; Shipp MA Blood; 1993 Dec; 82(12):3539-47. PubMed ID: 7505117 [TBL] [Abstract][Full Text] [Related]
63. Transient expression of CD44 variant isoforms in the ontogeny of the rat: ectoderm-, endoderm- and mesoderm-derived cells express different exon combinations. Weber B; Rösel M; Arch R; Möller P; Zöller M Differentiation; 1996 Mar; 60(1):17-29. PubMed ID: 8935925 [TBL] [Abstract][Full Text] [Related]
64. Molecular detection of cancer cells by competitive reverse transcription-polymerase chain reaction analysis of specific CD44 variant RNAs. Okamoto I; Morisaki T; Sasaki J; Miyake H; Matsumoto M; Suga M; Ando M; Saya H J Natl Cancer Inst; 1998 Feb; 90(4):307-15. PubMed ID: 9486817 [TBL] [Abstract][Full Text] [Related]
65. The expression patterns of standard and variant CD44 molecules in normal uterine cervix and cervical cancer. Shimabukuro K; Toyama-Sorimachi N; Ozaki Y; Goi T; Furukawa K; Miyasaka M; Aso T Gynecol Oncol; 1997 Jan; 64(1):26-34. PubMed ID: 8995543 [TBL] [Abstract][Full Text] [Related]
66. A new alternatively spliced exon between v9 and v10 provides a molecular basis for synthesis of soluble CD44. Yu Q; Toole BP J Biol Chem; 1996 Aug; 271(34):20603-7. PubMed ID: 8702806 [TBL] [Abstract][Full Text] [Related]
67. Prognostic significance of CD44v6/v7 in acute promyelocytic leukemia. Chen P; Huang HF; Lu R; Wu Y; Chen YZ Asian Pac J Cancer Prev; 2012; 13(8):3791-4. PubMed ID: 23098472 [TBL] [Abstract][Full Text] [Related]
68. Importance of different CD44v6 expression in human gastric intestinal and diffuse type cancers for metastatic lymphogenic spreading. Dämmrich J; Vollmers HP; Heider KH; Müller-Hermelink HK J Mol Med (Berl); 1995 Aug; 73(8):395-401. PubMed ID: 8528741 [TBL] [Abstract][Full Text] [Related]
69. Expression of CD44 and its clinical implication in diffuse-type and intestinal-type gastric adenocarcinomas. Hong RL; Lee WJ; Shun CT; Chu JS; Chen YC Oncology; 1995; 52(4):334-9. PubMed ID: 7539903 [TBL] [Abstract][Full Text] [Related]
70. Differential expression of CD44 splice variants in malignant and benign pleural effusions. Tojo N; Inase N; Ichioka M; Miyazato I; Nara N Tohoku J Exp Med; 1996 Aug; 179(4):273-9. PubMed ID: 8944429 [TBL] [Abstract][Full Text] [Related]
71. Splice variants of the cell surface glycoprotein CD44 associated with metastatic tumour cells are expressed in normal tissues of humans and cynomolgus monkeys. Heider KH; Mulder JW; Ostermann E; Susani S; Patzelt E; Pals ST; Adolf GR Eur J Cancer; 1995 Dec; 31A(13-14):2385-91. PubMed ID: 8652273 [TBL] [Abstract][Full Text] [Related]
72. De novo expression of CD44 variants in sporadic and hereditary gastric cancer. da Cunha CB; Oliveira C; Wen X; Gomes B; Sousa S; Suriano G; Grellier M; Huntsman DG; Carneiro F; Granja PL; Seruca R Lab Invest; 2010 Nov; 90(11):1604-14. PubMed ID: 20856229 [TBL] [Abstract][Full Text] [Related]
73. Expression of antisense CD44 variant 6 inhibits colorectal tumor metastasis and tumor growth in a wound environment. Reeder JA; Gotley DC; Walsh MD; Fawcett J; Antalis TM Cancer Res; 1998 Aug; 58(16):3719-26. PubMed ID: 9721884 [TBL] [Abstract][Full Text] [Related]
74. Enhanced cell surface CD44 variant (v6, v9) expression by osteopontin in breast cancer epithelial cells facilitates tumor cell migration: novel post-transcriptional, post-translational regulation. Khan SA; Cook AC; Kappil M; Günthert U; Chambers AF; Tuck AB; Denhardt DT Clin Exp Metastasis; 2005; 22(8):663-73. PubMed ID: 16691370 [TBL] [Abstract][Full Text] [Related]
75. Regulated expression of exon v6 containing isoforms of CD44 in man: downregulation during malignant transformation of tumors of squamocellular origin. Salmi M; Grön-Virta K; Sointu P; Grenman R; Kalimo H; Jalkanen S J Cell Biol; 1993 Jul; 122(2):431-42. PubMed ID: 8320265 [TBL] [Abstract][Full Text] [Related]
76. Expression of CD44 isoforms in human skin cancer. Simon JC; Heider KH; Dietrich A; Wuttig C; Schöpf E; Adolf GR; Ponta H; Herrlich P Eur J Cancer; 1996 Jul; 32A(8):1394-400. PubMed ID: 8869105 [TBL] [Abstract][Full Text] [Related]
78. Expression of CD44 standard and isoforms in human breast cancer xenografts and shedding of soluble forms into serum of nude mice. Fichtner I; Dehmel A; Naundorf H; Finke LH Anticancer Res; 1997; 17(5A):3633-45. PubMed ID: 9413216 [TBL] [Abstract][Full Text] [Related]
80. The prognostic value of CD44 isoforms in prostate cancer patients treated by radical prostatectomy. Noordzij MA; van Steenbrugge GJ; Verkaik NS; Schröder FH; van der Kwast TH Clin Cancer Res; 1997 May; 3(5):805-15. PubMed ID: 9815753 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]